Trulicity dosage: what the label actually says

Who does the label cover, and who does it not?

Patients aged 10 and older with type 2 diabetes are covered. They start where adults start, at 0.75 mg, and the label allows one step up to 1.5 mg. That is the end of the ladder for them. Nothing is established below age 10.

The Trulicity label covers type 2 diabetes and nothing else. It sets no dose for weight, and Lilly never gave dulaglutide a second brand for weight the way it gave tirzepatide one. Drugs@FDA lists dulaglutide under one application and no others, and that application is a biologics license — which is a route with no generic at the end of it.

What if a week gets missed?

The label ties the answer to the gap ahead rather than the gap behind. If the next scheduled dose is at least 3 days off, which is 72 hours, a missed dose can still go in. Under 3 days, the label says to skip it and take the next one on the usual day.

The label allows the weekly day to move as long as the last dose went in 3 or more days before the new day.

What does it come in?

The device matters for dosing, because some of these hold one dose and some hold four.

How long does it take to reach the 4.5 mg dose?

Week 13 at the earliest, from the label’s four-week minimum at each of the 3 steps.

Trulicity has 3 steps between the 0.75 mg start and the 4.5 mg ceiling. The label asks for at least four weeks on a dose before the next one. Four weeks at each step is where week 13 comes from.

The label does not print week numbers for Trulicity. It gives the first four weeks, and then the four-week rule. Week 13 is that rule applied step by step, not a number quoted off the page.

Week 13 is a floor, not a schedule. Nothing in the label says a person has to keep climbing, and a slower rise is a decision for whoever wrote the prescription.

Can you stay on a low dose of Trulicity?

The Trulicity label names no maintenance dosages at all, so it does not answer this.

The Trulicity label sets out a way to move up rather than a place to stop. It gives the 0.75 mg start, a step size, and the four-week interval between steps.

That silence is the finding, and it is unusual. Most labels in this class name the doses to settle on. This one describes a rule for moving up instead.

Every dose above the 0.75 mg start is described the same way.

How does the Trulicity ladder compare with every other GLP-1 brand?

Trulicity tops out at 4.5 mg once a week. Eight brands in this class stop in eight different places.

The table below compares the approved GLP-1 brands by their highest labeled dose. It is the only place the eight ladders are set out together.

Milligrams do not carry across molecules. 4.5 mg of dulaglutide is not comparable to 4.5 mg of anything else. The last column says so on every row where the drug substance differs.

Where two brands do share a drug substance, the comparison is real, because the same molecule is being measured. That is the case for exactly two pairs in the class.

Do the side effects change as the dose goes up?

The label does not publish side effects broken out by dose for Trulicity. It reports them across a whole trial.

This is the question the trial tables cannot answer. A label counts how many people reported something over a study, not which dose they were on that week.

The escalation itself is the closest thing to an answer the label gives. It exists because moving up slowly is how the trials were run. The four-week interval is part of the approved schedule, not advice added later.

Where a figure does exist it sits on the side-effect page for this brand. It is taken from the label’s own trial table, with the arm it belongs to.

Where to read next

1 pages sit next to this one, and each answers something this page deliberately does not.

• What Trulicity costs reads the price off the manufacturer’s own terms rather than the label, including who those terms shut out.